Who We Are

NeuroTrauma Sciences (NTS) is a biopharmaceutical company focused on developing neuroprotective and neurorestorative agents to treat brain injury including stroke, concussion, and the complications of traumatic brain injury (TBI).

What We Do

When someone suffers a serious brain injury there are currently no drugs available to alleviate the cognitive, functional, and neurobehavioral effects.

NTS is developing a portfolio of products designed to address these life impairing damages.

Our Team

Carl Long

Carl Long

Chief Operating Officer

Judy Hedstrom

Judy Hedstrom

VP Operations

David Fater

David Fater

Chief Administrative Officer; Director of Finance

Brent Miller, PhD

Brent Miller, PhD

VP Product & Portfolio Management

Dean Murphy, RAC

Dean Murphy, RAC

VP Regulatory Affairs & Quality Assurance

David Poulsen, PhD

David Poulsen, PhD

Chief Science Officer

Our Investors

NeuroTrauma Sciences LLC is a funded, privately held company.  Additional information on our investors may be made available upon request.

Contact Us